| Identification | Back Directory | [Name]
[1,1'-Biphenyl]-3,4-diol, 4'-[4-[2-[[(6R)-2-amino-4,5,6,7-tetrahydro-6-benzothiazolyl]propylamino]ethyl]-1-piperazinyl]- | [CAS]
1619269-19-0 | [Synonyms]
Tau-aggregation-IN-1 [1,1'-Biphenyl]-3,4-diol, 4'-[4-[2-[[(6R)-2-amino-4,5,6,7-tetrahydro-6-benzothiazolyl]propylamino]ethyl]-1-piperazinyl]- | [Molecular Formula]
C28H37N5O2S | [MOL File]
1619269-19-0.mol | [Molecular Weight]
507.7 |
| Hazard Information | Back Directory | [Uses]
Tau-aggregation-IN-1 (Compound D-519) is a tau441 protein aggregation inhibitor with an IC50 of 21 μM. Tau-aggregation-IN-1 is also a dopamine D2 and D3 receptor agonist[1]. | [IC 50]
D2 Receptor; D3 Receptor | [References]
[1] Iva Ziu, et al. The multifunctional dopamine D2/D3 receptor agonists also possess inhibitory activity against the full-length tau441 protein aggregation. Bioorg Med Chem. 2020 Sep 15;28(18):115667. DOI:10.1016/j.bmc.2020.115667 |
|
|